These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 26553921

  • 1. Behçet's disease ocular attack score 24 and visual outcome in patients with Behçet's disease.
    Tanaka R, Murata H, Takamoto M, Ohtomo K, Okinaga K, Yoshida A, Kawashima H, Nakahara H, Fujino Y, Kaburaki T.
    Br J Ophthalmol; 2016 Jul; 100(7):990-994. PubMed ID: 26553921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparisons of Clinical Features in Japanese Patients with Behçet's Uveitis Treated in the 1990s and the 2000s.
    Nakahara H, Kaburaki T, Tanaka R, Yoshida A, Takamoto M, Kawata M, Fujino Y, Kawashima H, Aihara M.
    Ocul Immunol Inflamm; 2020 Jul; 28(2):262-269. PubMed ID: 30806114
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E, Leccese P, Olivieri I, Latanza L.
    Clin Exp Rheumatol; 2014 Jul; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hijioka K, Shibuya E, Komae K, Hori J, Ohguro N, Sonoda KH, Mizuki N, Okada AA, Ishibashi T, Goto H, Mochizuki M.
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Ocular prognosis in Behçet's disease].
    Cochereau-Massin I, Wechsler B, Le Hoang P, Le Thi Huong Du, Girard B, Rousselie F, Godeau P.
    J Fr Ophtalmol; 1992 Oct; 15(5):343-7. PubMed ID: 1430813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease.
    Kaburaki T, Araki F, Takamoto M, Okinaga K, Yoshida A, Numaga J, Fujino Y, Kawashima H.
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):709-14. PubMed ID: 19997745
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Ocular manifestations in Behçet's disease].
    Zeghidi H, Saadoun D, Bodaghi B.
    Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.